105 filings
Page 3 of 6
8-K
e32kx9k3 2guzpewux
10 Jun 20
Submission of Matters to a Vote of Security Holders
4:03pm
8-K
w3iq8 6fo
30 Mar 20
Other Events
5:30pm
8-K
qo9oix453x4c9d
23 Mar 20
Changes in Registrant's Certifying Accountant
4:30pm
8-K
prakuj21ez
11 Feb 20
ArTara Therapeutics Appoints Blaine Davis as Chief Financial Officer
4:27pm
8-K
2hw6pp8fxcl
10 Jan 20
ArTara Therapeutics Completes Merger Transaction with Proteon Therapeutics
5:25pm
8-K
uaqkw9ygpxw
31 Dec 19
Other Events
4:06pm
8-K
so9q720hbdo
23 Dec 19
Departure of Directors or Certain Officers
5:00pm
8-K
fkm5x mth
21 Nov 19
Other Events
5:02pm
8-K
nl95eovxa udku3yu2ho
31 Oct 19
Proteon Therapeutics Announces Third Quarter 2019 Financial Results
5:00pm
8-K
2d8s02ykjl
10 Oct 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
8:30am
8-K
ngj6ot0
2 Oct 19
Departure of Directors or Certain Officers
5:00pm
8-K
ohxjajxxo obf1h4s
24 Sep 19
Other Events
4:17pm
8-K
lgz7wx6e
24 Sep 19
Entry into a Material Definitive Agreement
2:04pm
8-K
gdn1i4 sycl710hn9l
24 Sep 19
Proteon Therapeutics and ArTara Therapeutics Agree to Combine
11:26am
8-K
t9p u53lh7a1t2og4
15 Aug 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:00pm
8-K
x497v7v iqc
7 Aug 19
Proteon Therapeutics Announces Second Quarter 2019 Financial Results
8:00am
8-K
3mt1a
15 May 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
8:01am
8-K
3k3hlf 0cd8d
8 May 19
Proteon Therapeutics Announces First Quarter 2019 Financial Results
8:01am
8-K
b8agezp2h
15 Apr 19
Proteon Therapeutics Announces Review of Potential Strategic Transactions
4:30pm
8-K
ak6f3i1dbf79f7lf
28 Mar 19
Proteon Therapeutics Announces Top-Line Results From Phase 3 PATENCY-2 Clinical Trial of Vonapanitase in Radiocephalic Arteriovenous Fistulas
8:00am